Skip to main content
Signal8

Gresham Gwendolyn

SEC insider (Form 3/4/5 filer). CIK 0001842114. SVP at Core Laboratories Inc. /DE/ (CLB). 6 reported Form 4/5 transactions since Sep 2024; latest on Feb 12, 2026. Located in HOUSTON, TX.

Companies Gresham Gwendolyn has filed insider reports for

  • Core Laboratories Inc. /DE/ (CLB): Officer, SVP
Gresham Gwendolyn profile photo

Gresham Gwendolyn

CIK: 0001842114

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)2 (33.3%)

Derivative conversions

Awards (A)2 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)2 (33.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Core Laboratories Inc. /DE/ logo
CLB

Core Laboratories Inc. /DE/

Officer

Discretionary Trading P&L

Holdings

Transaction History (6 total)

  • Core Laboratories Inc. /DE/ logo
    CLB

    Core Laboratories Inc. /DE/

    Feb 12, 2026
    Award

    Performance Shares

    Direct
    33.5K shares-
  • Core Laboratories Inc. /DE/ logo
    CLB

    Core Laboratories Inc. /DE/

    Dec 31, 2025
    Tax Payment
    Direct
    19.3K shares at avg. $16.03$309K
  • Core Laboratories Inc. /DE/ logo
    CLB

    Core Laboratories Inc. /DE/

    Dec 31, 2025
    Exercise
    Direct
    25K shares-
  • Core Laboratories Inc. /DE/ logo
    CLB

    Core Laboratories Inc. /DE/

    Feb 13, 2025
    Award

    Performance Shares

    Direct
    32.9K shares-
  • Core Laboratories Inc. /DE/ logo
    CLB

    Core Laboratories Inc. /DE/

    Dec 31, 2024
    Tax Payment
    Direct
    6K shares at avg. $17.31$104K
  • Core Laboratories Inc. /DE/ logo
    CLB

    Core Laboratories Inc. /DE/

    Dec 31, 2024
    Exercise
    Direct
    9.6K shares-

1-6 of 6